<p>We developed a novel microfluidic platform to automatically barcode genomic DNA from individual cancer cells. Using this approach, we sequenced acute myeloid leukemia (AML) tumors targeting up to 62 loci relevant for the disease from thousands of cells. We predict that our platform will enable analysis of heterogeneity in AML and improve stratification and therapy selection.</p>

Single-Cell DNA Sequencing of AML with Droplet Microfluidics

Leukemia, Myeloid, Acute study with AMPLICON data on dbGaP (1 participants)

Single-Cell DNA Sequencing of AML with Droplet Microfluidics

Description

Applying For Access

Summary